BerGenBio: BerGenBio is a clinical-stage biopharmaceutical company focused on developing transformative drugs targeting AXL as a potential cornerstone of therapy for aggressive diseases, including immune-evasive, therapy resistant cancers. The company’s proprietary lead candidate, bemcentinib, is a potentially first-in-class selective AXL inhibitor in a broad phase II oncology clinical development programme focused on combination and single agent therapy in lung cancer, leukaemia and COVID19. A first-in-class functional blocking anti-AXL antibody, tilvestamab, is undergoing phase I clinical testing. In parallel, BerGenBio is developing companion diagnostic tests to identify patient populations most likely to benefit from bemcentinib: this is expected to facilitate more efficient registration trials supporting a precision medicine-based commercialisation strategy.

BerGenBio is based in Bergen, Norway with a subsidiary in Oxford, UK. The company is listed on the Oslo Stock Exchange (ticker: BGBIO).
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Phase l or ll
Disease Space
Oncology
Finance
Pre-Revenues
Listing
Europe, Public
Market Cap
100MM - 500MM
Website:
Profiles:
Address:
Jonas Lies vei 91
Bergen, Hordaland 5009
Norway

Company Participants at Solebury Trout Virtual Management Access Event - 1x1 conference calls

  • Richard Godfrey, CEO

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Lead Programs

Bemcentinib

Indication Phase
NSCLC 2
NSCLC 2
NSCLC 2
TNBC 2
Melanoma 2
AML 2

BGB149

Indication Phase
Cancer 1

Top 10 Holders of BerGenBio ASA

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Alfred Berg Kapitalforvaltning AS 8.19 4,959,833 24.99 Funds 2020-05-29
Nordea Investment Management AB (Norway) 6.89 4,169,462 21.01 Stakes 2019-12-31
KLP Kapitalforvaltning AS 5.48 3,315,806 16.71 Stakes 2019-12-31
MP Pensjon PK 1.73 1,045,555 5.27 Stakes 2019-12-31
DNB Asset Management AS 0.54 325,391 1.64 Funds 2020-04-30
Storebrand Asset Management AS 0.51 306,488 1.54 Funds 2020-06-30
Handelsbanken Kapitalforvaltning AS 0.29 174,115 0.88 Funds 2020-06-30
Handelsbanken Fonder AB 0.20 120,283 0.61 Funds 2020-06-30
Mackenzie Financial Corp. 0.00 1,778 0.01 Funds 2020-02-29
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.